1498.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 02:28):

Stats
Today's Volume	40 000.00
Average Volume	86 533.00
Market Cap	292.34M
EPS	HKD0 ( 2024-05-24 )
Last Dividend	HKD0.0191 ( 2017-05-31 )
Next Dividend	HKD0 ( N/A )
P/E	-2.74
ATR14	HKD0 (0.00%)

PuraPharm Corp Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PuraPharm Corp Ltd Financials

Annual	2023
Revenue:	HKD406.86M
Gross Profit:	HKD214.85M (52.81 %)
EPS:	HKD-0.270

FY	2023
Revenue:	HKD406.86M
Gross Profit:	HKD214.85M (52.81 %)
EPS:	HKD-0.270

FY	2022
Revenue:	HKD448.07M
Gross Profit:	HKD260.59M (58.16 %)
EPS:	HKD-0.300

FY	2021
Revenue:	HKD659.59M
Gross Profit:	HKD423.35M (64.18 %)
EPS:	HKD-0.329

Financial Reports:

No articles found.

PuraPharm Corp Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

PuraPharm Corp Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.0649 - low (50.00%) | Divividend Growth Potential Score: 1.355 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0840	2016-05-19
Last Dividend	HKD0.0191	2017-05-31
Next Dividend	HKD0	N/A
Payout Date	2017-06-23
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	HKD0.103	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	0.0649
Div.Growth Potential Score	1.355
Div. Directional Score	0.710	--

Next Divdend (Est)
(2025-03-31)

HKD0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2166.HK	Ex Dividend Knight	2023-06-05	Semi-Annually	0.00%
0987.HK	Ex Dividend Junior	2023-06-23	Annually	0.00%
0010.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
6123.HK	Ex Dividend Junior	2023-06-15	Annually	0.00%
1612.HK	Ex Dividend Knight	2023-09-05	Annually	0.00%
0533.HK	Ex Dividend Knight	2023-09-05	Semi-Annually	0.00%
2333.HK	Ex Dividend Knight	2023-06-29	Annually	0.00%
1133.HK	Ex Dividend Junior	2023-06-15	Sporadic	0.00%
0097.HK	Ex Dividend Junior	2023-06-07	Semi-Annually	0.00%
6969.HK	Ex Dividend Knight	2023-09-06	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.261	1.500	-5.21	-7.82	[0 - 0.5]
returnOnAssetsTTM	-0.126	1.200	-4.19	-5.03	[0 - 0.3]
returnOnEquityTTM	-0.574	1.500	-7.49	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.612	0.800	-1.939	-1.552	[1 - 3]
quickRatioTTM	0.320	0.800	-2.82	-2.26	[0.8 - 2.5]
cashRatioTTM	0.0827	1.500	-0.652	-0.978	[0.2 - 2]
debtRatioTTM	0.478	-1.500	2.04	-3.06	[0 - 0.6]
interestCoverageTTM	-1.882	1.000	-1.808	-1.808	[3 - 30]
operatingCashFlowPerShareTTM	0.137	2.00	9.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0818	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	2.63	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.528	1.000	4.53	4.53	[0.2 - 0.8]
operatingProfitMarginTTM	-0.127	1.000	-4.54	-4.54	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.134	1.000	-0.367	-0.367	[0.2 - 2]
assetTurnoverTTM	0.482	0.800	-0.119	-0.0956	[0.5 - 2]
Total Score				0.0649

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.76	1.000	-0.379	0	[1 - 100]
returnOnEquityTTM	-0.574	2.50	-4.81	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0818	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.137	2.00	9.95	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0250	1.500	-3.50	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.18	0	[0.1 - 0.5]
Total Score				1.355

PuraPharm Corp Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PuraPharm Corp Ltd

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.